Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Charlotte Gasson"'
Autor:
Michelle Levene, Dario Pacitti, Charlotte Gasson, Jamie Hall, Marcia Sellos-Moura, Bridget E. Bax
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 11, Iss , Pp 1-8 (2018)
Erythrocyte encapsulated thymidine phosphorylase is recombinant Escherichia coli thymidine phosphorylase encapsulated within human autologous erythrocytes and is under development as an enzyme replacement therapy for the ultra-rare inherited metaboli
Externí odkaz:
https://doaj.org/article/3f454fa28ac74ca78eedd5841cfa3eb9
Autor:
Jamie Hall, Marcia Sellos-Moura, Charlotte Gasson, Bridget E. Bax, Dario Pacitti, Michelle Levene
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 11, Iss, Pp 1-8 (2018)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods & Clinical Development
Erythrocyte encapsulated thymidine phosphorylase is recombinant Escherichia coli thymidine phosphorylase encapsulated within human autologous erythrocytes and is under development as an enzyme replacement therapy for the ultra-rare inherited metaboli
Autor:
Bridget E. Bax, Charlotte Gasson, David Coleman, Lynette D. Fairbanks, Babunilayam Gangadharan, Michelle Levene, Hugh C. Kilpatrick
Publikováno v:
Toxicological Sciences. 131:311-324
Erythrocyte-encapsulated thymidine phosphorylase (EE-TP) is currently under development as an enzyme replacement therapy for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), an autosomal recessive disorder caused by a deficiency of thym
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 72
Erythrocyte encapsulated thymidine phosphorylase (EE-TP) is under development as an enzyme replacement therapy for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), a fatal metabolic disorder resulting from an inherited deficiency of the